B

(redirected from Soft tissue sarcoma)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

B

Fifth letter of a Nasdaq stock descriptor specifying that issue is the Class B shares of the company.

B

1. On the NASDAQ stock exchange, a symbol on the ticker board indicating that the issue being traded is class B stock. That is, B represents common stock designated by the publicly-traded company issuing it as having fewer rights than class A stock, especially fewer voting rights.

2. A low bond rating used by the S&P and Fitch credit agencies. B-rated bonds are highly speculative and are thought to contain high risk and a relatively high chance of default. Banks are not permitted to invest in B-rated bonds. See also: Junk.

B

A low, speculative grade assigned to a debt obligation by a rating agency. Such a rating indicates there is considerable uncertainty as to the ability to pay interest and repay principal over a long period.

b

Used in the dividend column of stock transaction tables in newspapers to indicate payment of a stock dividend in addition to the indicated cash dividend: 1.50b.
References in periodicals archive ?
Multiple types of soft tissue sarcomas are defined based on the tissue of origin (Table 1).
Patients with locally advanced or relapsed metastatic soft tissue sarcomas who had disease progression following standard therapies including an anthracycline and at least one other additional regimen were recruited.
The other soft tissue sarcomas include epithelioid sarcoma (Figure 7) and angiosarcoma (Figure 8).
Core needle biopsy for diagnosis of extremity soft tissue sarcoma.
Sixty-seven soft tissue sarcomas were classified, graded, and analyzed for the expression of p53, mdm2, pRb, p16, cyclin D1, and cdk4.
We concluded from the trial data that aldoxorubicin is an active drug for the treatment of patients with metastatic soft tissue sarcomas who have progressed on prior chemotherapies, including those previously treated with doxorubicin," said Dr.
Patients with locally advanced or relapsed and metastatic soft tissue sarcomas who showed disease progression following standard therapies must have included an anthracycline and at least one other additional regimen.
Advanced soft tissue sarcoma is very difficult to treat, so we are excited to be one step closer to potentially bringing an additional treatment option to patients in need," said Kenichi Nomoto, Ph.
Eisai intends to submit applications during the first half of the fiscal year of 2015 to the regulatory authorities in multiple countries which include the United States, Europe and Japan seeking an expansion of the indication for eribulin including soft tissue sarcoma.
Aldoxorubicin May Be an Important Therapeutic Option for Patients with Advanced Soft Tissue Sarcoma, as Well as Other Solid Tumor Types